Metabolic phenotype in the mouse model of osteogenesis imperfecta
Osteogenesis imperfecta (OI) is the most common heritable bone fragility disorder, usually caused by dominant mutations in genes coding for collagen type I alpha chains, COL1A1 or COL1A2. Osteocalcin (OCN) is now recognized as a bone-derived regulator of insulin secretion and sensitivity and glucose...
Saved in:
Published in | Journal of endocrinology Vol. 234; no. 3; pp. 279 - 289 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Bioscientifica Ltd
01.09.2017
Portland Press Ltd The Biochemical Society |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Osteogenesis imperfecta (OI) is the most common heritable bone fragility disorder, usually caused by dominant mutations in genes coding for collagen type I alpha chains, COL1A1 or COL1A2. Osteocalcin (OCN) is now recognized as a bone-derived regulator of insulin secretion and sensitivity and glucose homeostasis. Since OI is associated with increased rates of bone formation and resorption, we hypothesized that the levels of undercarboxylated OCN are increased in OI. The objective of this study was to determine changes in OCN and to elucidate the metabolic phenotype in the Col1a1Jrt/+ mouse, a model of dominant OI caused by a Col1a1 mutation. Circulating levels of undercarboxylated OCN were higher in 4-week-old OI mice and normal by 8 weeks of age. Young OI animals exhibited a sex-dependent metabolic phenotype, including increased insulin levels in males, improved glucose tolerance in females, lower levels of random glucose and low adiposity in both sexes. The rates of O2 consumption and CO2 production, as well as energy expenditure assessed using indirect calorimetry were significantly increased in OI animals of both sexes, whereas respiratory exchange ratio was significantly higher in OI males only. Although OI mice have significant physical impairment that may contribute to metabolic differences, we specifically accounted for movement and compared OI and WT animals during the periods of similar activity levels. Taken together, our data strongly suggest that OI animals have alterations in whole body energy metabolism that are consistent with the action of undercarboxylated osteocalcin. |
---|---|
AbstractList | Osteogenesis imperfecta (OI) is the most common heritable bone fragility disorder, usually caused by dominant mutations in genes coding for collagen type I alpha chains, COL1A1 or COL1A2. Osteocalcin (OCN) is now recognized as a bone-derived regulator of insulin secretion and sensitivity and glucose homeostasis. Since OI is associated with increased rates of bone formation and resorption, we hypothesized that the levels of undercarboxylated OCN are increased in OI. The objective of this study was to determine changes in OCN and to elucidate the metabolic phenotype in the Col1a1Jrt/+ mouse, a model of dominant OI caused by a Col1a1 mutation. Circulating levels of undercarboxylated OCN were higher in 4-week-old OI mice and normal by 8 weeks of age. Young OI animals exhibited a sex-dependent metabolic phenotype, including increased insulin levels in males, improved glucose tolerance in females, lower levels of random glucose and low adiposity in both sexes. The rates of O2 consumption and CO2 production, as well as energy expenditure assessed using indirect calorimetry were significantly increased in OI animals of both sexes, whereas respiratory exchange ratio was significantly higher in OI males only. Although OI mice have significant physical impairment that may contribute to metabolic differences, we specifically accounted for movement and compared OI and WT animals during the periods of similar activity levels. Taken together, our data strongly suggest that OI animals have alterations in whole body energy metabolism that are consistent with the action of undercarboxylated osteocalcin. Osteogenesis imperfecta (OI) is the most common heritable bone fragility disorder, usually caused by dominant mutations in genes coding for collagen type I alpha chains, COL1A1 or COL1A2 . Osteocalcin (OCN) is now recognized as a bone-derived regulator of insulin secretion and sensitivity and glucose homeostasis. Since OI is associated with increased rates of bone formation and resorption, we hypothesized that the levels of undercarboxylated OCN are increased in OI. The objective of this study was to determine changes in OCN and to elucidate the metabolic phenotype in the Col1a1 Jrt/+ mouse, a model of dominant OI caused by a Col1a1 mutation. Circulating levels of undercarboxylated OCN were higher in 4-week-old OI mice and normal by 8 weeks of age. Young OI animals exhibited a sex-dependent metabolic phenotype, including increased insulin levels in males, improved glucose tolerance in females, lower levels of random glucose and low adiposity in both sexes. The rates of O 2 consumption and CO 2 production, as well as energy expenditure assessed using indirect calorimetry were significantly increased in OI animals of both sexes, whereas respiratory exchange ratio was significantly higher in OI males only. Although OI mice have significant physical impairment that may contribute to metabolic differences, we specifically accounted for movement and compared OI and WT animals during the periods of similar activity levels. Taken together, our data strongly suggest that OI animals have alterations in whole body energy metabolism that are consistent with the action of undercarboxylated osteocalcin. Osteogenesis imperfecta (OI) is the most common heritable bone fragility disorder, usually caused by dominant mutations in genes coding for collagen type I alpha chains, or Osteocalcin (OCN) is now recognized as a bone-derived regulator of insulin secretion and sensitivity and glucose homeostasis. Since OI is associated with increased rates of bone formation and resorption, we hypothesized that the levels of undercarboxylated OCN are increased in OI. The objective of this study was to determine changes in OCN and to elucidate the metabolic phenotype in the Col1a1 mouse, a model of dominant OI caused by a mutation. Circulating levels of undercarboxylated OCN were higher in 4-week-old OI mice and normal by 8 weeks of age. Young OI animals exhibited a sex-dependent metabolic phenotype, including increased insulin levels in males, improved glucose tolerance in females, lower levels of random glucose and low adiposity in both sexes. The rates of O consumption and CO production, as well as energy expenditure assessed using indirect calorimetry were significantly increased in OI animals of both sexes, whereas respiratory exchange ratio was significantly higher in OI males only. Although OI mice have significant physical impairment that may contribute to metabolic differences, we specifically accounted for movement and compared OI and WT animals during the periods of similar activity levels. Taken together, our data strongly suggest that OI animals have alterations in whole body energy metabolism that are consistent with the action of undercarboxylated osteocalcin. Osteogenesis imperfecta (OI) is the most common heritable bone fragility disorder, usually caused by dominant mutations in genes coding for collagen type I alpha chains, COL1A1 or COL1A2 Osteocalcin (OCN) is now recognized as a bone-derived regulator of insulin secretion and sensitivity and glucose homeostasis. Since OI is associated with increased rates of bone formation and resorption, we hypothesized that the levels of undercarboxylated OCN are increased in OI. The objective of this study was to determine changes in OCN and to elucidate the metabolic phenotype in the Col1a1Jrt/+ mouse, a model of dominant OI caused by a Col1a1 mutation. Circulating levels of undercarboxylated OCN were higher in 4-week-old OI mice and normal by 8 weeks of age. Young OI animals exhibited a sex-dependent metabolic phenotype, including increased insulin levels in males, improved glucose tolerance in females, lower levels of random glucose and low adiposity in both sexes. The rates of O2 consumption and CO2 production, as well as energy expenditure assessed using indirect calorimetry were significantly increased in OI animals of both sexes, whereas respiratory exchange ratio was significantly higher in OI males only. Although OI mice have significant physical impairment that may contribute to metabolic differences, we specifically accounted for movement and compared OI and WT animals during the periods of similar activity levels. Taken together, our data strongly suggest that OI animals have alterations in whole body energy metabolism that are consistent with the action of undercarboxylated osteocalcin.Osteogenesis imperfecta (OI) is the most common heritable bone fragility disorder, usually caused by dominant mutations in genes coding for collagen type I alpha chains, COL1A1 or COL1A2 Osteocalcin (OCN) is now recognized as a bone-derived regulator of insulin secretion and sensitivity and glucose homeostasis. Since OI is associated with increased rates of bone formation and resorption, we hypothesized that the levels of undercarboxylated OCN are increased in OI. The objective of this study was to determine changes in OCN and to elucidate the metabolic phenotype in the Col1a1Jrt/+ mouse, a model of dominant OI caused by a Col1a1 mutation. Circulating levels of undercarboxylated OCN were higher in 4-week-old OI mice and normal by 8 weeks of age. Young OI animals exhibited a sex-dependent metabolic phenotype, including increased insulin levels in males, improved glucose tolerance in females, lower levels of random glucose and low adiposity in both sexes. The rates of O2 consumption and CO2 production, as well as energy expenditure assessed using indirect calorimetry were significantly increased in OI animals of both sexes, whereas respiratory exchange ratio was significantly higher in OI males only. Although OI mice have significant physical impairment that may contribute to metabolic differences, we specifically accounted for movement and compared OI and WT animals during the periods of similar activity levels. Taken together, our data strongly suggest that OI animals have alterations in whole body energy metabolism that are consistent with the action of undercarboxylated osteocalcin. |
Author | Guillemette, Delphine Ferron, Mathieu Komarova, Svetlana V Lefebvre, Geneviève Boraschi-Diaz, Iris Tauer, Josephine T Rauch, Frank El-Rifai, Omar |
AuthorAffiliation | Unité de Recherche en Physiologie Intégrative et Moléculaire, Institut de Recherches Cliniques de Montréal, Montréal, Québec, Canada Shriners Hospital for Children-Canada, Montreal, Quebec, Canada Département de Mathématiques, Université du Québec à Montréal, Montréal, Québec, Canada Faculty of Dentistry, McGill University, Montreal, Quebec, Canada Départements de Médecine et de Biochimie et Médecine Moléculaire, Université de Montréal, Montréal, Québec, Canada |
AuthorAffiliation_xml | – name: Département de Mathématiques, Université du Québec à Montréal, Montréal, Québec, Canada – name: Shriners Hospital for Children-Canada, Montreal, Quebec, Canada – name: Unité de Recherche en Physiologie Intégrative et Moléculaire, Institut de Recherches Cliniques de Montréal, Montréal, Québec, Canada – name: Départements de Médecine et de Biochimie et Médecine Moléculaire, Université de Montréal, Montréal, Québec, Canada – name: Faculty of Dentistry, McGill University, Montreal, Quebec, Canada |
Author_xml | – sequence: 1 givenname: Iris surname: Boraschi-Diaz fullname: Boraschi-Diaz, Iris organization: Faculty of Dentistry, McGill University, Montreal, Quebec, Canada – sequence: 2 givenname: Josephine T surname: Tauer fullname: Tauer, Josephine T organization: Shriners Hospital for Children-Canada, Montreal, Quebec, Canada – sequence: 3 givenname: Omar surname: El-Rifai fullname: El-Rifai, Omar organization: Unité de Recherche en Physiologie Intégrative et Moléculaire, Institut de Recherches Cliniques de Montréal, Montréal, Québec, Canada – sequence: 4 givenname: Delphine surname: Guillemette fullname: Guillemette, Delphine organization: Département de Mathématiques, Université du Québec à Montréal, Montréal, Québec, Canada – sequence: 5 givenname: Geneviève surname: Lefebvre fullname: Lefebvre, Geneviève organization: Département de Mathématiques, Université du Québec à Montréal, Montréal, Québec, Canada – sequence: 6 givenname: Frank surname: Rauch fullname: Rauch, Frank organization: Shriners Hospital for Children-Canada, Montreal, Quebec, Canada – sequence: 7 givenname: Mathieu surname: Ferron fullname: Ferron, Mathieu organization: Départements de Médecine et de Biochimie et Médecine Moléculaire, Université de Montréal, Montréal, Québec, Canada – sequence: 8 givenname: Svetlana V surname: Komarova fullname: Komarova, Svetlana V email: svetlana.komarova@mcgill.ca organization: Faculty of Dentistry, McGill University, Montreal, Quebec, Canada |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28716975$$D View this record in MEDLINE/PubMed |
BookMark | eNp90D1PwzAQBmALgWgLTOwoEgsSCtixHdtjVZUvgbrAHDnJmbpK7BA7Q_89qQoMHVjuluc-9M7QsfMOELok-I5wiu9fVsuUiBRTyo_QlDCh0lxifoymGGdZioXiEzQLYYMx4UTQUzTJpCC5EnyK5m8QdekbWyXdGpyP2w4S65K4hqT1Q9jVGprEm8SHCP4THAQbEtt20Buooj5HJ0Y3AS5--hn6eFi-L57S19Xj82L-mpaUq5jqUnJWa5aTGnRJhaFUSMkMz0AzXivFS5qJWmghGabAcoFlLmltMDXGVJqeoZv93q73XwOEWLQ2VNA02sH4aEFURghlivORXh_QjR96N343KsmoJFzJUV39qKFsoS663ra63xa_4Yzgdg-q3ofQg_kjBBe76Isx-oKIYhf9qMmBrmzU0XoXe22b_2dK60NlwUVrbKX_vfMN_DyUoA |
CitedBy_id | crossref_primary_10_1021_acsptsci_3c00324 crossref_primary_10_1007_s00223_024_01320_2 crossref_primary_10_1038_s41413_020_00122_0 crossref_primary_10_1159_000481918 crossref_primary_10_1016_j_ymgme_2021_02_004 crossref_primary_10_1016_j_bonr_2018_06_008 crossref_primary_10_1002_jbmr_4529 crossref_primary_10_3390_cells9122630 crossref_primary_10_1016_j_ymgme_2022_06_004 crossref_primary_10_3390_ijms22094963 crossref_primary_10_3390_ijms24010184 crossref_primary_10_1016_j_ymgme_2021_03_014 crossref_primary_10_1093_jbmrpl_ziae112 crossref_primary_10_3390_cells11233943 crossref_primary_10_1002_jbmr_3732 crossref_primary_10_1080_03008207_2022_2161376 crossref_primary_10_1002_jbm4_10753 crossref_primary_10_1007_s11914_018_0456_6 crossref_primary_10_1038_s44161_022_00018_8 crossref_primary_10_3390_ijms22010429 crossref_primary_10_1016_j_bone_2021_115940 crossref_primary_10_1371_journal_pgen_1008938 crossref_primary_10_1002_1873_3468_14259 |
Cites_doi | 10.1016/j.molmet.2016.07.002 10.1111/j.1469-185X.1974.tb01171.x 10.1016/j.jpeds.2015.10.058 10.1097/BRS.0b013e31811ec2d9 10.1016/j.bone.2015.05.019 10.1007/s11832-012-0385-3 10.1161/ATVBAHA.110.204859 10.1016/j.nut.2011.04.003 10.1016/j.bone.2011.06.018 10.1073/pnas.0711119105 10.1359/jbmr.091109 10.1016/j.cell.2007.05.047 10.1016/j.bbrc.2010.06.008 10.1007/s00431-016-2839-y 10.1210/endo.143.5.8807 10.1210/jc.2008-1422 10.1007/s00198-016-3501-2 10.1083/jcb.201409111 10.1016/S8756-3282(00)00269-6 10.1038/nature10763 10.1002/jbmr.2177 10.1038/nrendo.2011.81 10.1359/jbmr.090720 10.1542/peds.49.3.375 10.1016/j.molmet.2013.08.004 10.1359/jbmr.081225 10.1016/j.bone.2014.06.015 10.1016/j.cell.2010.06.003 10.1136/adc.86.5.356 10.1016/j.bone.2014.10.012 10.1016/j.bone.2011.04.017 10.1359/JBMR.040111 10.1056/NEJM199810013391402 10.1038/382448a0 10.1016/j.bone.2015.08.001 10.1080/01621459.1963.10500845 10.1359/jbmr.080804 10.2353/ajpath.2010.090704 10.1038/pr.2015.230 |
ContentType | Journal Article |
Copyright | 2017 Society for Endocrinology 2017 Society for Endocrinology. Copyright Portland Press Ltd The Biochemical Society Sep 2017 |
Copyright_xml | – notice: 2017 Society for Endocrinology – notice: 2017 Society for Endocrinology. – notice: Copyright Portland Press Ltd The Biochemical Society Sep 2017 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7TK K9. 7X8 |
DOI | 10.1530/JOE-17-0335 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Neurosciences Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Calcium & Calcified Tissue Abstracts Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
DocumentTitleAlternate | Metabolic phenotype in OI |
EISSN | 1479-6805 |
EndPage | 289 |
ExternalDocumentID | 28716975 10_1530_JOE_17_0335 |
Genre | Journal Article |
GroupedDBID | - 02 08R 0R 2WC 3O- 4.4 53G 55 5GY 5RE 5VS AAFZV AAYJJ ABFLS ABLYK ABOCM ABPTK ABSGY ABSQV ACNCT ACPRK ADACO ADBBV ADBIT ADDZX AENEX AFDAS AFFNX AGCAB ALMA_UNASSIGNED_HOLDINGS BAWUL CS3 DIK DU5 E3Z EBS EJD F5P FA8 FH7 GJ GX1 H13 HZ H~9 IL9 INIJC J5H K-O KM KQ8 L7B MVM O0- O9- OHT OK1 P2P REN RHF TBS VH1 WH7 WOQ X X7M XJT ZA5 ZGI ZXP --- -~X .55 .GJ 0R~ 18M AALGN AAYXX ACGFO ADMOG AFHIN AFOSN AI. BTFSW CITATION F9R HF~ HZ~ W8F WHG ~02 ~KM CGR CUY CVF ECM EIF NPM 7QP 7TK K9. 7X8 |
ID | FETCH-LOGICAL-b359t-ab854da461deab37f337884f52ea45d995b327d7a78403e46708683df03fffca3 |
ISSN | 0022-0795 1479-6805 |
IngestDate | Fri Jul 11 01:22:20 EDT 2025 Mon Jun 30 11:35:55 EDT 2025 Thu Apr 03 07:04:27 EDT 2025 Thu Apr 24 22:58:51 EDT 2025 Thu Jul 03 08:36:15 EDT 2025 Wed Apr 14 02:20:59 EDT 2021 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | glucose homeostasis undercarboxylated osteocalcin metabolism osteogenesis imperfecta indirect calorimetry |
Language | English |
License | 2017 Society for Endocrinology. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-b359t-ab854da461deab37f337884f52ea45d995b327d7a78403e46708683df03fffca3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | http://dx.doi.org/10.1530/JOE-17-0335 |
PMID | 28716975 |
PQID | 1984381598 |
PQPubID | 2046244 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_1921134955 proquest_journals_1984381598 pubmed_primary_28716975 crossref_primary_10_1530_JOE_17_0335 crossref_citationtrail_10_1530_JOE_17_0335 bioscientifica_primary_10_1530_JOE_17_0335 |
PublicationCentury | 2000 |
PublicationDate | 20170900 2017-09-00 2017-Sep 20170901 |
PublicationDateYYYYMMDD | 2017-09-01 |
PublicationDate_xml | – month: 09 year: 2017 text: 20170900 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Bristol |
PublicationTitle | Journal of endocrinology |
PublicationTitleAlternate | J Endocrinol |
PublicationYear | 2017 |
Publisher | Bioscientifica Ltd Portland Press Ltd The Biochemical Society |
Publisher_xml | – name: Bioscientifica Ltd – name: Portland Press Ltd The Biochemical Society |
References | (ref421) 2015; 81 (ref831) 2003; 12 (ref201) 2017; 176 (ref381) 2015; 79 (ref761) 2014; 66 (ref51) 2014; 29 (ref601) 1998; 339 (ref771) 2010; 30 (ref161) 2012; 50 (ref131) 2012; 50 (ref801) 2015; 79 (ref511) 1996; 382 (ref311) 2000; 26 (ref401) 2007; 32 (ref31) 2016; 27 (ref571) 2011; 7 (ref231) 2004; 19 (ref621) 2017; 176 (ref331) 2012 (ref661) 2013; 2 (ref101) 2008; 105 (ref521) 2008; 105 (ref111) 2010a; 142 (ref151) 2011; 7 (ref61) 2009; 24 (ref361) 2015; 71 (ref681) 2010; 176 (ref261) 2010; 176 (ref791) 2008; 23 (ref491) 1972; 49 (ref301) 2014; 14 (ref591) 2016; 79 (ref611) 1974; 49 (ref371) 2008; 23 (ref211) 2002; 143 (ref21) 2002; 86 (ref711) 2009; 94 (ref191) 1974; 49 (ref321) 2010; 25 (ref671) 2007; 130 (ref651) 2004; 19 (ref251) 2007; 130 (ref121) 2010b; 397 (ref701) 2016; 169 (ref291) 2009; 94 (ref221) 2012; 481 (ref01) 2015; 81 (ref141) 2015; 208 (ref81) 2010; 25 (ref481) 2009; 24 (ref451) 2016; 27 (ref641) 2012; 481 (ref471) 2014; 29 (ref551) 2012; 50 (ref11) 2012; 6 (ref721) 2014; 14 (ref341) 2014; 66 (ref631) 2002; 143 (ref91) 1996; 382 (ref581) 2012; 50 (ref561) 2015; 208 (ref431) 2012; 6 (ref411) 2003; 12 (ref691) 2016; 5 (ref461) 2012; 28 (ref501) 2010; 25 (ref741) 2010; 25 (ref241) 2013; 2 (ref71) 1972; 49 (ref441) 2002; 86 (ref181) 1998; 339 (ref41) 2012; 28 (ref541) 2010b; 397 (ref271) 2016; 5 (ref811) 1963; 58 (ref781) 2015; 71 (ref351) 2010; 30 (ref731) 2000; 26 (ref751) 2012 (ref281) 2016; 169 (ref531) 2010a; 142 (ref171) 2016; 79 (ref391) 1963; 58 (ref821) 2007; 32 |
References_xml | – volume: 5 start-page: 1042 year: 2016 ident: ref691 article-title: Osteocalcin is necessary and sufficient to maintain muscle mass in older mice publication-title: Molecular Metabolism doi: 10.1016/j.molmet.2016.07.002 – volume: 12 start-page: 77 year: 2003 ident: ref831 article-title: Modern approach to children with osteogenesis imperfecta publication-title: Journal of Pediatric Orthopaedics B – volume: 49 start-page: 423 year: 1974 ident: ref611 article-title: Sexual dimorphism in mammals publication-title: Biological Reviews doi: 10.1111/j.1469-185X.1974.tb01171.x – volume: 169 start-page: 232 year: 2016 ident: ref281 article-title: Body Composition in Children and Adolescents with Osteogenesis Imperfecta publication-title: Journal of Pediatrics doi: 10.1016/j.jpeds.2015.10.058 – volume-title: Methods of Multivariate Analysis year: 2012 ident: ref331 – volume: 32 start-page: 488 year: 2007 ident: ref821 article-title: Correlation of scoliotic curvature with Z-score bone mineral density and body mass index in patients with osteogenesis imperfecta publication-title: Spine doi: 10.1097/BRS.0b013e31811ec2d9 – volume: 79 start-page: 52 year: 2015 ident: ref801 article-title: The functional muscle-bone unit in patients with osteogenesis imperfecta type I publication-title: Bone doi: 10.1016/j.bone.2015.05.019 – volume: 6 start-page: 29 year: 2012 ident: ref431 article-title: A scoring system for the assessment of clinical severity in osteogenesis imperfecta publication-title: Journal of Children’s Orthopaedics doi: 10.1007/s11832-012-0385-3 – volume: 30 start-page: 1474 year: 2010 ident: ref771 article-title: Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome publication-title: Arteriosclerosis, Thrombosis, and Vascular Biology doi: 10.1161/ATVBAHA.110.204859 – volume: 28 start-page: 138 year: 2012 ident: ref461 article-title: Do patients with osteogenesis imperfecta need individualized nutritional support? publication-title: Nutrition doi: 10.1016/j.nut.2011.04.003 – volume: 50 start-page: 452 year: 2012 ident: ref161 article-title: Novel functions for insulin in bone publication-title: Bone doi: 10.1016/j.bone.2011.06.018 – volume: 105 start-page: 5266 year: 2008 ident: ref101 article-title: Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. publication-title: PNAS doi: 10.1073/pnas.0711119105 – volume: 25 start-page: 1367 year: 2010 ident: ref741 article-title: Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta publication-title: Journal of Bone and Mineral Research doi: 10.1359/jbmr.091109 – volume: 130 start-page: 456 year: 2007 ident: ref671 article-title: Endocrine regulation of energy metabolism by the skeleton publication-title: Cell doi: 10.1016/j.cell.2007.05.047 – volume: 397 start-page: 691 year: 2010b ident: ref541 article-title: An ELISA-based method to quantify osteocalcin carboxylation in mice publication-title: Biochemical and Biophysical Research Communications doi: 10.1016/j.bbrc.2010.06.008 – volume: 176 start-page: 311 year: 2017 ident: ref201 article-title: Developmental charts for children with osteogenesis imperfecta, type I (body height, body weight and BMI) publication-title: European Journal of Pediatrics doi: 10.1007/s00431-016-2839-y – volume: 143 start-page: 1594 year: 2002 ident: ref211 article-title: Osteoblastic response to the defective matrix in the osteogenesis imperfecta murine (oim) mouse publication-title: Endocrinology doi: 10.1210/endo.143.5.8807 – volume: 94 start-page: 827 year: 2009 ident: ref291 article-title: Association between serum osteocalcin and markers of metabolic phenotype publication-title: Journal of Clinical Endocrinology and Metabolism doi: 10.1210/jc.2008-1422 – volume: 27 start-page: 2355 year: 2016 ident: ref31 article-title: Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-α publication-title: Osteoporosis International doi: 10.1007/s00198-016-3501-2 – volume: 208 start-page: 761 year: 2015 ident: ref141 article-title: GGCX and VKORC1 inhibit osteocalcin endocrine functions publication-title: Journal of Cell Biology doi: 10.1083/jcb.201409111 – volume: 26 start-page: 581 year: 2000 ident: ref311 article-title: Static and dynamic bone histomorphometry in children with osteogenesis imperfecta publication-title: Bone doi: 10.1016/S8756-3282(00)00269-6 – volume: 481 start-page: 314 year: 2012 ident: ref641 article-title: The contribution of bone to whole-organism physiology publication-title: Nature doi: 10.1038/nature10763 – volume: 49 start-page: 423 year: 1974 ident: ref191 article-title: Sexual dimorphism in mammals publication-title: Biological Reviews doi: 10.1111/j.1469-185X.1974.tb01171.x – volume: 29 start-page: 1412 year: 2014 ident: ref51 article-title: First mouse model for combined osteogenesis imperfecta and ehlers-danlos syndrome publication-title: Journal of Bone and Mineral Research doi: 10.1002/jbmr.2177 – volume: 7 start-page: 540 year: 2011 ident: ref151 article-title: New perspectives on osteogenesis imperfecta publication-title: Nature Reviews Endocrinology doi: 10.1038/nrendo.2011.81 – volume: 25 start-page: 247 year: 2010 ident: ref81 article-title: Variable bone fragility associated with an Amish COL1A2 variant and a knock-in mouse model publication-title: Journal of Bone and Mineral Research doi: 10.1359/jbmr.090720 – volume: 49 start-page: 375 year: 1972 ident: ref491 article-title: Physiological evidence of hypermetabolism in osteogenesis imperfecta publication-title: Pediatrics doi: 10.1542/peds.49.3.375 – volume: 2 start-page: 498 year: 2013 ident: ref661 article-title: In vivo analysis of the contribution of bone resorption to the control of glucose metabolism in mice publication-title: Molecular Metabolism doi: 10.1016/j.molmet.2013.08.004 – volume: 176 start-page: 311 year: 2017 ident: ref621 article-title: Developmental charts for children with osteogenesis imperfecta, type I (body height, body weight and BMI) publication-title: European Journal of Pediatrics doi: 10.1007/s00431-016-2839-y – volume: 25 start-page: 1367 year: 2010 ident: ref321 article-title: Relationship between genotype and skeletal phenotype in children and adolescents with osteogenesis imperfecta publication-title: Journal of Bone and Mineral Research doi: 10.1359/jbmr.091109 – volume: 24 start-page: 669– year: 2009 ident: ref481 article-title: Large osteoclasts in pediatric osteogenesis imperfecta patients receiving intravenous pamidronate publication-title: Journal of Bone and Mineral Research doi: 10.1359/jbmr.081225 – volume: 66 start-page: 182 year: 2014 ident: ref761 article-title: Effect of sclerostin antibody treatment in a mouse model of severe osteogenesis imperfecta publication-title: Bone doi: 10.1016/j.bone.2014.06.015 – volume: 142 start-page: 296 year: 2010a ident: ref111 article-title: Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism publication-title: Cell doi: 10.1016/j.cell.2010.06.003 – volume: 481 start-page: 314 year: 2012 ident: ref221 article-title: The contribution of bone to whole-organism physiology publication-title: Nature doi: 10.1038/nature10763 – volume: 28 start-page: 138 year: 2012 ident: ref41 article-title: Do patients with osteogenesis imperfecta need individualized nutritional support? publication-title: Nutrition doi: 10.1016/j.nut.2011.04.003 – volume: 86 start-page: 356 year: 2002 ident: ref21 article-title: Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta publication-title: Archives of Disease in Childhood doi: 10.1136/adc.86.5.356 – volume: 71 start-page: 115 year: 2015 ident: ref361 article-title: Rapidly growing Brtl/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment publication-title: Bone doi: 10.1016/j.bone.2014.10.012 – volume: 50 start-page: 568 year: 2012 ident: ref551 article-title: Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice publication-title: Bone doi: 10.1016/j.bone.2011.04.017 – volume: 19 start-page: 614 year: 2004 ident: ref231 article-title: Brittle IV mouse model for osteogenesis imperfecta IV demonstrates postpubertal adaptations to improve whole bone strength publication-title: Journal of Bone and Mineral Research doi: 10.1359/JBMR.040111 – volume: 143 start-page: 1594 year: 2002 ident: ref631 article-title: Osteoblastic response to the defective matrix in the osteogenesis imperfecta murine (oim) mouse publication-title: Endocrinology doi: 10.1210/endo.143.5.8807 – volume: 14 start-page: 155 year: 2014 ident: ref721 article-title: Validity of an accelerometer as a vertical ground reaction force measuring device in healthy children and adolescents and in children and adolescents with osteogenesis imperfecta type I publication-title: Journal of Musculoskeletal and Neuronal Interactions – volume: 339 start-page: 947 year: 1998 ident: ref601 article-title: Cyclic administration of pamidronate in children with severe osteogenesis imperfecta publication-title: New England Journal of Medicine doi: 10.1056/NEJM199810013391402 – volume: 7 start-page: 540 year: 2011 ident: ref571 article-title: New perspectives on osteogenesis imperfecta publication-title: Nature Reviews Endocrinology doi: 10.1038/nrendo.2011.81 – volume: 382 start-page: 448 year: 1996 ident: ref91 article-title: Increased bone formation in osteocalcin-deficient mice publication-title: Nature doi: 10.1038/382448a0 – volume: 94 start-page: 827 year: 2009 ident: ref711 article-title: Association between serum osteocalcin and markers of metabolic phenotype publication-title: Journal of Clinical Endocrinology and Metabolism doi: 10.1210/jc.2008-1422 – volume: 79 start-page: 52 year: 2015 ident: ref381 article-title: The functional muscle-bone unit in patients with osteogenesis imperfecta type I publication-title: Bone doi: 10.1016/j.bone.2015.05.019 – volume: 81 start-page: 400– year: 2015 ident: ref421 article-title: Behavioral signs of pain and functional impairment in a mouse model of osteogenesis imperfecta publication-title: Bone doi: 10.1016/j.bone.2015.08.001 – volume: 169 start-page: 232 year: 2016 ident: ref701 article-title: Body Composition in Children and Adolescents with Osteogenesis Imperfecta publication-title: Journal of Pediatrics doi: 10.1016/j.jpeds.2015.10.058 – volume: 208 start-page: 761 year: 2015 ident: ref561 article-title: GGCX and VKORC1 inhibit osteocalcin endocrine functions publication-title: Journal of Cell Biology doi: 10.1083/jcb.201409111 – volume: 6 start-page: 29 year: 2012 ident: ref11 article-title: A scoring system for the assessment of clinical severity in osteogenesis imperfecta publication-title: Journal of Children’s Orthopaedics doi: 10.1007/s11832-012-0385-3 – volume: 339 start-page: 947 year: 1998 ident: ref181 article-title: Cyclic administration of pamidronate in children with severe osteogenesis imperfecta publication-title: New England Journal of Medicine doi: 10.1056/NEJM199810013391402 – volume: 5 start-page: 1042 year: 2016 ident: ref271 article-title: Osteocalcin is necessary and sufficient to maintain muscle mass in older mice publication-title: Molecular Metabolism doi: 10.1016/j.molmet.2016.07.002 – volume: 26 start-page: 581 year: 2000 ident: ref731 article-title: Static and dynamic bone histomorphometry in children with osteogenesis imperfecta publication-title: Bone doi: 10.1016/S8756-3282(00)00269-6 – volume: 19 start-page: 614 year: 2004 ident: ref651 article-title: Brittle IV mouse model for osteogenesis imperfecta IV demonstrates postpubertal adaptations to improve whole bone strength publication-title: Journal of Bone and Mineral Research doi: 10.1359/JBMR.040111 – volume-title: Methods of Multivariate Analysis year: 2012 ident: ref751 – volume: 50 start-page: 568 year: 2012 ident: ref131 article-title: Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice publication-title: Bone doi: 10.1016/j.bone.2011.04.017 – volume: 49 start-page: 375 year: 1972 ident: ref71 article-title: Physiological evidence of hypermetabolism in osteogenesis imperfecta publication-title: Pediatrics doi: 10.1542/peds.49.3.375 – volume: 58 start-page: 236 year: 1963 ident: ref391 article-title: Hierarchical grouping to optimize an objective function publication-title: Journal of the American Statistical Association doi: 10.1080/01621459.1963.10500845 – volume: 397 start-page: 691 year: 2010b ident: ref121 article-title: An ELISA-based method to quantify osteocalcin carboxylation in mice publication-title: Biochemical and Biophysical Research Communications doi: 10.1016/j.bbrc.2010.06.008 – volume: 29 start-page: 1412 year: 2014 ident: ref471 article-title: First mouse model for combined osteogenesis imperfecta and ehlers-danlos syndrome publication-title: Journal of Bone and Mineral Research doi: 10.1002/jbmr.2177 – volume: 142 start-page: 296 year: 2010a ident: ref531 article-title: Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism publication-title: Cell doi: 10.1016/j.cell.2010.06.003 – volume: 66 start-page: 182 year: 2014 ident: ref341 article-title: Effect of sclerostin antibody treatment in a mouse model of severe osteogenesis imperfecta publication-title: Bone doi: 10.1016/j.bone.2014.06.015 – volume: 24 start-page: 669– year: 2009 ident: ref61 article-title: Large osteoclasts in pediatric osteogenesis imperfecta patients receiving intravenous pamidronate publication-title: Journal of Bone and Mineral Research doi: 10.1359/jbmr.081225 – volume: 27 start-page: 2355 year: 2016 ident: ref451 article-title: Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-α publication-title: Osteoporosis International doi: 10.1007/s00198-016-3501-2 – volume: 30 start-page: 1474 year: 2010 ident: ref351 article-title: Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome publication-title: Arteriosclerosis, Thrombosis, and Vascular Biology doi: 10.1161/ATVBAHA.110.204859 – volume: 2 start-page: 498 year: 2013 ident: ref241 article-title: In vivo analysis of the contribution of bone resorption to the control of glucose metabolism in mice publication-title: Molecular Metabolism doi: 10.1016/j.molmet.2013.08.004 – volume: 71 start-page: 115 year: 2015 ident: ref781 article-title: Rapidly growing Brtl/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment publication-title: Bone doi: 10.1016/j.bone.2014.10.012 – volume: 23 start-page: 1983 year: 2008 ident: ref371 article-title: Cellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursors publication-title: Journal of Bone and Mineral Research doi: 10.1359/jbmr.080804 – volume: 176 start-page: 2405 year: 2010 ident: ref681 article-title: Immature Osteoblast Lineage Cells Increase Osteoclastogenesis in Osteogenesis Imperfecta Murine publication-title: American Journal of Pathology doi: 10.2353/ajpath.2010.090704 – volume: 23 start-page: 1983 year: 2008 ident: ref791 article-title: Cellular mechanism of decreased bone in Brtl mouse model of OI: imbalance of decreased osteoblast function and increased osteoclasts and their precursors publication-title: Journal of Bone and Mineral Research doi: 10.1359/jbmr.080804 – volume: 81 start-page: 400– year: 2015 ident: ref01 article-title: Behavioral signs of pain and functional impairment in a mouse model of osteogenesis imperfecta publication-title: Bone doi: 10.1016/j.bone.2015.08.001 – volume: 14 start-page: 155 year: 2014 ident: ref301 article-title: Validity of an accelerometer as a vertical ground reaction force measuring device in healthy children and adolescents and in children and adolescents with osteogenesis imperfecta type I publication-title: Journal of Musculoskeletal and Neuronal Interactions – volume: 58 start-page: 236 year: 1963 ident: ref811 article-title: Hierarchical grouping to optimize an objective function publication-title: Journal of the American Statistical Association doi: 10.1080/01621459.1963.10500845 – volume: 79 start-page: 489 year: 2016 ident: ref591 article-title: Cross-sectional and longitudinal growth patterns in osteogenesis imperfecta: implications for clinical care publication-title: Pediatric Research doi: 10.1038/pr.2015.230 – volume: 86 start-page: 356 year: 2002 ident: ref441 article-title: Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta publication-title: Archives of Disease in Childhood doi: 10.1136/adc.86.5.356 – volume: 32 start-page: 488 year: 2007 ident: ref401 article-title: Correlation of scoliotic curvature with Z-score bone mineral density and body mass index in patients with osteogenesis imperfecta publication-title: Spine doi: 10.1097/BRS.0b013e31811ec2d9 – volume: 12 start-page: 77 year: 2003 ident: ref411 article-title: Modern approach to children with osteogenesis imperfecta publication-title: Journal of Pediatric Orthopaedics B – volume: 382 start-page: 448 year: 1996 ident: ref511 article-title: Increased bone formation in osteocalcin-deficient mice publication-title: Nature doi: 10.1038/382448a0 – volume: 105 start-page: 5266 year: 2008 ident: ref521 article-title: Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. publication-title: PNAS doi: 10.1073/pnas.0711119105 – volume: 176 start-page: 2405 year: 2010 ident: ref261 article-title: Immature Osteoblast Lineage Cells Increase Osteoclastogenesis in Osteogenesis Imperfecta Murine publication-title: American Journal of Pathology doi: 10.2353/ajpath.2010.090704 – volume: 79 start-page: 489 year: 2016 ident: ref171 article-title: Cross-sectional and longitudinal growth patterns in osteogenesis imperfecta: implications for clinical care publication-title: Pediatric Research doi: 10.1038/pr.2015.230 – volume: 25 start-page: 247 year: 2010 ident: ref501 article-title: Variable bone fragility associated with an Amish COL1A2 variant and a knock-in mouse model publication-title: Journal of Bone and Mineral Research doi: 10.1359/jbmr.090720 – volume: 130 start-page: 456 year: 2007 ident: ref251 article-title: Endocrine regulation of energy metabolism by the skeleton publication-title: Cell doi: 10.1016/j.cell.2007.05.047 – volume: 50 start-page: 452 year: 2012 ident: ref581 article-title: Novel functions for insulin in bone publication-title: Bone doi: 10.1016/j.bone.2011.06.018 |
SSID | ssj0015173 |
Score | 2.346409 |
Snippet | Osteogenesis imperfecta (OI) is the most common heritable bone fragility disorder, usually caused by dominant mutations in genes coding for collagen type I... |
SourceID | proquest pubmed crossref bioscientifica |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 279 |
SubjectTerms | Adipose tissue Animals Bone growth Bone resorption Calorimetry Carbon dioxide Collagen (type I) Collagen Type I - genetics Collagen Type I - metabolism Disease Models, Animal Energy expenditure Energy metabolism Female Genotype & phenotype Glucose tolerance Hereditary diseases Homeostasis Humans Insulin Insulin secretion Male Metabolism Mice Mutation Osteocalcin Osteocalcin - genetics Osteocalcin - metabolism Osteogenesis Osteogenesis imperfecta Osteogenesis Imperfecta - genetics Osteogenesis Imperfecta - metabolism Phenotype Rodents Secretion |
Title | Metabolic phenotype in the mouse model of osteogenesis imperfecta |
URI | http://dx.doi.org/10.1530/JOE-17-0335 https://www.ncbi.nlm.nih.gov/pubmed/28716975 https://www.proquest.com/docview/1984381598 https://www.proquest.com/docview/1921134955 |
Volume | 234 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKkBBIINj4GAxkpIkHJLO2tvPxWKDbhNpVQq3UN8tObBSpTdCWPsBfz52dph10aPASVanjRHfn8935d3eEHCfCSS5MxBxoPiaE6zGthWZgysrMpLBDdjF3eHwRnc_El7mcdzqjLdTSqjYfsp8780r-h6twD_iKWbL_wNl2UrgBv4G_cAUOw_VWPB7bGniIZaoRqVX5cGqDW0SP3oY-N2gPYipH9Q31WnGFmZH2EmEc-gbT1JZ5Bdrkesj9IwgLuMIF-1xoH3XG5vQbx38VeB9OFNB0bdHXwwX7WrjQ9nqy1C0a-GyFeYhLxBoFzbfwD27HIWBvWwOt1qpTxCmLkm44o7Y77jX6tt9EL4ttfzxoz9BX5g-tLrlvWD0ZMnwt53Kzea0P7C8m6nQ2GqnpcD69Q-72wWnAfhZn8xbwA6aNxxu039Rka8LkJ1tTPyAPTRHqiHqw1m8Gyw1eiLdGpo_Jo4ZXdBBk4gnp2HKfHAxKXVfLH_Qd9cBez759cm_c4CcOyKCVGNpKDC1KChJDvcRQLzG0cnRbYuhGYp6S2elw-umcNU00mOEyrZk2iRS5FlEvt9rw2HHsIAArtG-1kHmaSsP7cR7rGFx9bmHfBCc34bnrcudcpvkzsldWpX1BaCwyF2dJJjMBdqdMksylWSaSKDW5cTY-JO-vk059DxVTFHqaQGcFdFa9WCGdYfCarCprytFjV5TF7sHH7eC_znm05o9qlumV6qUJlrGTaXJI3rZ_gxLFkzFdWiCuwqKAWKdTwhTPA1_b9_iQQhrLl7d4-hW5v1kaR2SvvlzZ12C01uaNl8Vf8Q2Xuw |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Metabolic+phenotype+in+the+mouse+model+of+osteogenesis+imperfecta&rft.jtitle=Journal+of+endocrinology&rft.au=Boraschi-Diaz%2C+Iris&rft.au=Tauer%2C+Josephine+T&rft.au=El-Rifai%2C+Omar&rft.au=Guillemette%2C+Delphine&rft.date=2017-09-01&rft.issn=1479-6805&rft.eissn=1479-6805&rft.volume=234&rft.issue=3&rft.spage=279&rft_id=info:doi/10.1530%2FJOE-17-0335&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-0795&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-0795&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-0795&client=summon |